The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Poluéktov M.G.

Kurs somnologii pri kafedre nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Pchelina P.V.

Sechenov First Moscow State Medical University, Moscow

Insomnia due to hypnotic abuse

Authors:

Poluéktov M.G., Pchelina P.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11‑2): 24‑29

DOI: 10.17116/jnevro201611611224-29

Read: 10752 times

Download PDF (RU)
Contact the author
Table of contents

INSOMNIA DUE TO HYPNOTIC ABUSE
INSOMNIA DUE TO HYPNOTIC ABUSE

To cite this article:

Poluéktov MG, Pchelina PV. Insomnia due to hypnotic abuse. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11‑2):24‑29. (In Russ.)
https://doi.org/10.17116/jnevro201611611224-29

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inso­mnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51
The use of zolpidem in the treatment of acute and chro­nic inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):52-56
The pote­ntial of neurofeedback control in treating inso­mnia and improving sleep quality (a systematic review). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):57-63
Effe­cts of rhythmic transcranial magnetic stimulation in the treatment of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69
Clinical and dyna­mic features of alco­holism formation in middle-aged and elde­rly patients with primary orga­nic mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):73-78
Vali­dation of ballistocardiography data for predicting the sleep effi­ciency in healthy indi­viduals and patients with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):60-66
Carbonyl stress in meno­pausal women with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):192-197
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Abstract:

Insomnia due to hypnotic abuse and dependence is a common and serious problem of somnology irrespectively of which one comes first: sleep disturbances or drug use. Modern hypnotics demonstrate selective affinity to some types of benzodiazepine receptors. This explains its higher safety profile compared to first-generation hypnotics. Nevertheless, there are reports of dependence and withdrawal syndrome associated with its administration as well. This literature review shows that seizures, hemodynamic and respiratory disturbances are the most dangerous symptoms of withdrawal. Treatment of hypnotic dependence includes detoxication and gradual withdrawal of medicines.

Keywords:

insomnia
benzodiazepines
withdrawal syndrome
drug tolerance

Authors:

Poluéktov M.G.

Kurs somnologii pri kafedre nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Pchelina P.V.

Sechenov First Moscow State Medical University, Moscow

Close metadata

References:

  1. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep. 2000;23:23-30.
  2. American Psychiatric Association. DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Washington, DC: American Psychiatric Publishing; 2013.
  3. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Westchester, Ill: American Academy of Sleep Medicine; 2005.
  4. American Academy of Sleep Medicine. The International classification of sleep disorders [Diagnostic and coding manual]. Darien, U.S.A: American Academy of Sleep Medicine; 2014.
  5. Johnson E.O., Breslau N. Sleep problems and substance use in adolescence. Drug and Alcohol Dependence. 2001;62:1-7.
  6. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Department of Health and Human Services (HHS); 2015.
  7. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorder: a longitudinal epidemiological study of young adults. Biological Psychiatry 1996;39:411-418.
  8. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.The TEDS Report: Substance Abuse Treatment Admissions for Abuse of Benzodiazepines. Rockville, MD: Department of Health and Human Services (HHS); 2011.
  9. Golenkov AV, Poluektov MG. Rasprostranennost' narushenii sna u zhitelei Chuvashii (dannye sploshnogo anketnogo oprosa). Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2011;111:6:64-67. (In Russ.).
  10. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence andcorrelates. Archives of General Psychiatry. 1985;42:225-232.
  11. Walsh JK, Roth T. Pharmacologic treatment of insomnia: benzodiazepine receptor agonists. In: M.H. Kryger, T. Roth, W.C. Dement. Eds. Principles and practice of sleep medicine — 5th ed. St. Louis, Missouri: Elsevier Saunders; 2011.
  12. Vimont C. Sleep Problems and Substance Use Disorders: An Often Overlooked Link. July 26, 2013. Ссылка активна на 15.10.15. Доступно по: http://www.drugfree.org/join-together/sleep-problems-and-substance-use-disorders-an-often-overlooked-link/
  13. Mahfoud Y, Talih F, Streem D, Budur K. Sleep disorders in substance abusers: how common are they? Psychiatry (Edgemont.) 2009;6(9):38-42.
  14. Roth T. Insomnia: Definition, Prevalence, Etiology, and Consequences. Journal of Clinical Sleep Medicine. 2007;3(5 suppl):7-10. doi:10.1016/s1098-3597(03)90031-7
  15. Poluektov MG, Levin YaI. eds. Somnologiya i meditsina sna. M.: Medforum; 2013. (In Russ.).
  16. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC. Central nervous system-active medications and risk for falls in older women. Journal of American Geriatric Society. 2002;50:1629-1637.
  17. Kessler RC, McGonagle KA, Shanyang Z, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States Results From the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8-19.
  18. Pagel JF, Parnes BL. Medications for the treatment of sleep disorders: an overview. Journal of Clinical Psychiatry. 2001;3:118-125.
  19. Vinkers CH, Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA-A Receptor Modulators? Advances in Pharmacological Sciences 2012;1-19.
  20. Wojcik SM, Tantra M, Stepniak B, Man KM, Müller-Ribbe K, Begemann M, Ju A, Papiol S, Ronnenberg A, Gurvich A, Shin Y, Augustin I, Brose N, Ehrenreich H. Genetic Markers of a Munc13 Protein Family Member, BAIAP3, Are Gender Specifically Associated with Anxiety and Benzodiazepine Abuse in Mice and Humans. Molecular Medicine. 2013;19:135-148.
  21. Kolb B, Whishaw I. An Introduction to Brain and Behavior. New York: Worth Publishers; 2014.
  22. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia and hypnotic self administration. Psychopharmacology. 1992;107:480-484.
  23. Tsai MJ, Huang YB, Wu PC. A novel clinical pattern of visual hallucination after zolpidem use. Journal of Toxicology: Clinical Toxicology. 2003;41(6):869-872.
  24. Poluektov MG, Levin YaI, Mikhailov VA, Babak SL, Strygin KN. The use of trittico (trazodone) for the treatment of sleep disorders in depression: results of multicenter study. Effectivnaya pharmacotherapija. 2013;12:82-90. (In Russ.).
  25. Weaver MD. Prescription Sedative Misuse and Abuse. Yale Journal of biology and medicine. 2015;88:247-256.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.